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Background: Sperm banking is recommended for all men diagnosed with cancer where treatment is associated with risk of long-
term gonadatoxicity, to offer the opportunity of fatherhood and improved quality of life. However, uptake of sperm banking is
lower than expected and little is known about why men refuse. Our aims were to determine: (i) demographic and medical variables
associated with decisions about banking and (ii) differences in quality of life between bankers and non-bankers at diagnosis
(Time 1 (T1)) and 1 year later (Time 2 (T2)).
Methods: Questionnaires were completed by 91 men (response rate¼ 86.67%) at T1 and 78 (85.71% response rate) at T2.
Results: In all, 44 (56.41%) banked sperm. They were younger and less likely to have children than non-bankers. In a subset of men
who were not sure if they wanted children in the future (n¼ 36), 24 banked sperm. Among this group, those who banked were
younger, more satisfied with clinic appointments and less worried about the health of future children. At T2, there were no
differences in quality of life between bankers and non-bankers.
Conclusion: For those who are uncertain about future reproductive plans, decisions depend on their health on diagnosis and
satisfaction with clinic care. We conclude that extra care should be taken in counselling younger men who may have given little
consideration to future parenting. Results support previous findings that the role of the doctor is vital in facilitating decisions,
especially for those who are undecided about whether they wanted children in the future or not.
Survival rates for most cancers continue to improve, but physical
and psychological late effects are increasingly recognised (Ganz,
2010), including risks of infertility (Wallace and Thomson, 2003;
Pacey, 2007). As infertility cannot always be predicted, it is
recommended that sperm banking is offered to all postpubertal
male subjects where there is a risk of long-term gonadal damage
(National Collaborating Centre for Women’s and Children’s
Health, 2004; ESHRE, 2004; Lee et al, 2006; Royal College of
Physicians, 2007). In this way, men who survive cancer have the
opportunity to father a child after treatment with positive
implications for their health-related quality of life (HRQoL).
Although young men diagnosed with cancer are concerned
about the risk of infertility (Schover et al, 1999; Tschudin and
Bitzer, 2009), data indicate that sperm banking services are
underutilised (Pacey and Eiser, 2011). Previous work (Magelssen
et al, 2005; Girasole et al, 2007; Klosky et al, 2009) suggests only
24–31% of men accept the opportunity to bank sperm at diagnosis.
The most common reasons to decline the offer of banking sperm
are not wanting children in the future, and prior sterilisation of
them (vasectomy) or their partner (tubal ligation). Those who are
single at the time of diagnosis feel too old to have children or are
advised that sperm banking is not necessary are also less likely to
bank (Gilbert et al, 2011; Quinn et al, 2011). Concern about
treatment delays (Schover et al, 1999) and pressures to begin
cancer treatment quickly may cause decisions about sperm banking
to be hurried or poorly considered (Zapzalka et al, 1999;
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Schover et al, 2002). Some men are concerned about abnormalities
and teratogenic risk for children born from frozen sperm (Lass et al,
2001), and this may influence their decision to accept the offer.
Conversely, those who do decide to bank sperm are typically of
higher socioeconomic status (Klosky et al, 2009), younger, less
likely to have children before diagnosis (Schover et al, 2002) and
more optimistic about survival (Achille et al, 2006). Yee et al
(2011) found a major factor in men’s decision to bank was future
family planning and others commented on the psychological
benefits of banking (Saito et al, 2005) and how it gave them a ‘sense
of hope’ and ‘peace of mind’ before starting treatment (Pacey,
2003; Eiser et al, 2011).
Oncologists also have a key role in men’s decisions (Schover
et al, 2002; Saito et al, 2005). Both Eiser et al (2011) and Yee et al
(2011) found many men banked sperm simply because it was what
their doctor/oncologist advised: they attended appointments at the
sperm bank in much the same way as they attended for blood tests
and scans. The decision to bank sperm necessitates more hospital
appointments and increased contact with clinic staff, so that those
who are more satisfied with their initial care may be more likely to
accept the doctor’s recommendations (Loblaw et al, 1999).
Conversely, barriers to effective communication between doctor
and patient, or the lack of relevant or easily accessible information
about sperm banking, may hamper decision-making (Achille et al,
2006; Gilbert et al, 2011; Quinn et al, 2011).
The wish to have children after treatment is consistently given
as the reason why men bank sperm, but this raises the question
about what motivates men to bank when they are unsure about
whether or not they want children in the future. Given the
relatively young age on diagnosis of some cancers, (Office for
National Statistics, 2012), it is likely that many men diagnosed with
testicular cancer may not have given much thought to starting a
family. Previous research offers only limited perspectives about
these young men and failure to recognise this may partly explain
why statistics suggest that men are reluctant to take up banking
services: they are undecided about how much they want children in
the future (whether or not they already have children) and
therefore decline the offer without much thought.
With few exceptions, past work has focused on the variables
associated with the decision to bank but has not considered the
longer-term consequences for HRQoL. Most work suggests that
long-term HRQoL among men following testicular cancer is as
good as the general population (Rossen et al, 2009), although there
may be some compromise in physical HRQoL and among those
with more side effects (Mykletun et al, 2005). Cancer survivors
who chose not to bank and subsequently became infertile after
treatment reported substantial psychosocial distress (Green et al,
2003; Neal et al, 2007). In that sperm banking has been construed
as a means to enhance long-term HRQoL, we specifically evaluated
any differences between bankers and non-bankers over the first
year following diagnosis, with the expectation that bankers might
report higher HRQoL.
Our aims were therefore first to identify medical, demographic
and psychological variables on diagnosis (T1) and 1 year later (T2),
which differentiate between bankers and non-bankers, and second
to determine HRQoL among a sample of young men where
treatment poses a risk to their fertility. We conducted separate
analyses including the subset of men who were unsure at T1 about
their desire for fatherhood in the future.
MATERIALS AND METHODS
Procedure. Between July 2008 and August 2010, a sequential
cohort of men diagnosed with either testicular cancer or a
haematological disorder in two teaching hospitals in the north of
England (Sheffield and Leeds) were approached to take part in the
study. These groups were selected because they represent the most
common diagnoses in men of reproductive age and the most
frequently referred reasons for sperm banking (Pacey and Eiser,
2011). Eligibility criteria included male subjects aged 18–45 years,
diagnoses of testicular or haematological cancer with good
prognoses and undergoing treatment with curative intent, no
known mental health problems and sufficient English language
ability to provide written informed consent and complete
questionnaires. A research nurse approached eligible patients at
the clinic appointment when sperm banking was discussed and
men were invited to participate regardless of their decision to bank
sperm. Meetings were held between the two medical teams
throughout the study to ensure standard procedures. Men who
agreed to participate were asked to complete questionnaires as
soon as possible (T1) and again 1 year later at a routine follow-up
visit (T2). Extra time was given at each appointment for
men to complete their questionnaires. All recruitment procedures
were approved by the Trent Research Ethics Committee (Ref:
07/H0405/61).
Measures. Background information was collected about age
(years), partner status (single, partner but not living together,
married/living with partner, divorced/separated or widowed), age
left full-time education (16 or under, 17–18, 19–21 or 21þ ),
employment (work full-time, work part-time, on sick leave,
student, homemaker, retired, unemployed, other), ethnicity (white,
mixed, Asian or Asian British, Black or Black British, Chinese or
Chinese British, other), living status (alone, with friends, with a
partner, with parents, other) and number of children (biological,
adopted, born using sperm from a donor and step-children).
T1 self-report measures. Health-related quality of life (QLQ-C30)
is a 30-item measure, which is typically scored to yield a global
health status scale, five functional scales and nine symptom scales/
items (Aaronson et al, 1993). The five functional scales include
physical function (five items), role function (two items), emotional
function (four items), social function (two items) and cognitive
function (two items). The nine symptom scales include fatigue
(three items), nausea and vomiting (two items), and pain (two
items), and single items to assess dyspnoea, insomnia, appetite loss,
constipation, diarrhoea and financial impact. Higher scores on
functional scales and global health status indicate good HRQoL,
whereas higher scores on symptom items and scales represent poor
HRQoL. The measure has been found to yield high test–retest
reliability in patients with various cancer diagnoses (Hjermstad
et al, 2005). We followed a recent approach to analyses described
by Hinz et al (2012), which results in the calculation of three
scores: function, symptoms and a total score.
Views of clinic appointments were assessed using the Princess
Margaret Hospital Patient Satisfaction With Doctor Questionnaire
(PMH/PSQ-MD). This scale was developed to assess satisfaction
among cancer patients and includes 29 items grouped into four
subscales (information exchange, interpersonal skills, empathy and
quality of time; Loblaw et al, 1999). Excellent reliability (a¼ 0.97)
and validity have been demonstrated. We calculated a total
satisfaction score based on two subscales measuring ‘Information
exchange’ (nine items) and ‘Quality of time’ (five items).
Responses were made on five-point Likert scales from ‘strongly
agree’ to ‘strongly disagree’, with higher scores representing greater
satisfaction.
Illness perceptions (Brief Illness Perception Questionnaire-
Revised: BIPQR; Broadbent et al, 2006): The BIPQR includes
eight items, of which five assess cognitive illness representations
(consequences, timeline, personal control, treatment control and
identity), two assess emotional representations (concern and
emotions) and one assesses illness comprehensibility. An addi-
tional item, ‘How much do you think your illness has affected your
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fertility (ability to have children)’ was added (but was scored
separately). All items were rated on a 0 to 10 response scale, with
higher scores reflecting a more threatening view of the illness.
A mean score based on all the items, as well as the individual items,
were used in the analysis.
Views about sperm banking: Based on our literature review and
clinical experience, we constructed a 15-item measure of men’s
views about sperm banking (e.g. I don’t think my fertility is good
enough to make banking worthwhile; I understand the benefits of
banking before cancer treatment). Responses were made on four-
point Likert scales from ‘strongly agree’ to ‘strongly disagree’.
Views about parenting: We used five questions originally
described by Schover et al (1999, 2002) to assess men’s attitudes
to having children in the future, ‘How much has your experience of
cancer affected your wish to have children in future?’ ‘How much
do you want to have a child in future?’, ‘I worry that children born
from banked sperm will have health problems’, ‘I worry that my
cancer treatment could cause health problems for any child born
afterwards’ and ‘Before your cancer diagnosis, were you ever
worried that you had fertility problems?’ Responses were made on
five-point scales with appropriate end points (e.g. ‘strongly agree’
to ‘strongly disagree’). The five items were analysed individually.
Information about fertility: A series of multiple-choice questions
was used to determine the sources of information about possible
infertility after cancer treatment and the availability of banking
sperm (referral doctor, general practitioner nurse, social worker,
oncologist, other health professional, family/friend or none of the
above). Men were also asked to indicate if they accessed any
written information (booklet, websites or other). One or more
options could be ticked for each question.
T2 self-report measures. In addition to the above, at T2 four
questions were asked about how many samples the men banked
(0, 1, 2–3, 4–5, can’t remember), the quality of their banked
samples (‘I did not have any sperm to bank’, ‘good enough for
fertility treatment’ or ‘don’t know’), how confident they were that
they made the right decision about banking and how important it
is to know about changes in their fertility (rated on five-point
Likert scales ‘not at all’ to ‘very’). Each of these items was analysed
individually.
Views about fertility included six questions about men’s
understanding about changes in their fertility after cancer
treatment (Pacey et al, 2012). Responses were made on five-point
Likert scales from ‘strongly agree’ to ‘strongly disagree’. Two items
measured men’s confidence in fertility recovery: ‘I am certain my
fertility has already or will recover’ and ‘I am confident my fertility
is normal/as good as any other man of my age’. Higher scores
represented higher confidence in fertility recovery. Four items
measured Importance of fertility monitoring: ‘I don’t want to know
if my fertility has recovered or not’, ‘Information about my fertility
will make no difference to my behaviour’, ‘There are worse things
to worry about than being infertile’ and ‘I like to know as much as
possible about the effects of treatment on my fertility’. Higher
scores represent greater importance placed on monitoring fertility.
Medical and sperm banking information. Information on
diagnosis, treatment and oncology follow-ups was obtained from
medical records and information about the banked sperm was
collected for those who decided to bank sperm. This included
information on the prefreeze sample quality and also the consent
given with regard to the use of banked sperm.
Analysis. All data were entered independently by two authors and
checked for accuracy using SPSS version 16. Continuous variables
were standardised before analysis. Independent samples t-tests and
w2 analyses were used to check for differences between study sites.
For our sample, we examined the association between banking
decision at T1 and demographic, medical and psychological
variables using univariate logistic regression analyses. The extent
to which these simple relationships were independent of each other
was determined by multivariable hierarchical logistic regression
analysis. Following Hosmer and Lemeshow (2000), we tested for
significant non-linearity in the relationship of continuous pre-
dictors with the logit of the dependent variable. In multiple
predictor models, we inspected for evidence of multicollinearity.
Differences between bankers and non-bankers in HRQoL at T1
and T2 were explored using repeated measures ANOVA with one
between-participants factor (Bank: bankers vs non-bankers) and
one within-participants factor (Time: T1 vs T2). Independent
samples t-tests were used to compare bankers and non-bankers on
items asked at T2 only.
We created a subset of men who were unsure on diagnosis about
whether they wanted children in the future by excluding all men
who responded ‘definitely want a child in the future’ or ‘definitely
do not want a child in the future’ to the question ‘How much do
you want to have a child in the future’. We used univariate logistic
regression analyses to identify predictors of banking in this
subsample. We did not construct a multiple predictor model with
these data owing to the small sample size.
Treatment of measured variables. To create meaningfully sized
groups, background variables were dichotomised as follows:
partner status (partner vs single/separated), age left full-time
education (under 18 years vs over 18 years), employment (working
full/part-time vs not working), ethnicity (white vs other) and living
status (partner vs other).
Scores on the EORTC QLQ-C30 were calculated using the
algorithms provided by the EORTC group, where scores are
linearly transformed to give a range of 0–100 (Fayers et al, 1995).
Following the method tested by Hinz et al (2012), we calculated
three sum scores: function, symptoms and a total score. This
method was chosen in preference to averaging across the 15
separate items, to prevent higher weight being given to scales with
more than one response (e.g. physical function¼ 5; symptoms¼
three symptom scales: pain, fatigue and nausea//vomiting and six
single items) than those with fewer items. A total score was
calculated by reverse coding the symptom items and averaging all
the function and symptom scales, along with the global health
status scale. Higher scores on the function and total scores
represent higher HRQoL, but higher scores on the symptoms score
equal low HRQoL. As expected, the distribution of the HRQoL
scores deviated substantially from normality, and scores were
therefore dichotomised using median splits, as described by
previous authors (Hayden et al, 2004; Snyder et al, 2009).
Subsequent comparisons were made between the highest- and
lowest-scoring halves.
Most scales were found to have good reliability (aX0.70):
satisfaction with clinic appointments (a¼ 0.87), information
exchange (0.74) and quality of time (0.85), and illness perceptions
(0.70). The three HRQoL scales all had good reliability: function
(0.76), symptom (0.82) and total score (0.90). On views to fertility,
the same factor solution reported by Pacey et al (2012) was present
in this population. However, while confidence in fertility recovery
had a high reliability (0.86), importance of fertility monitoring did
not (0.51), and the items in this scale were analysed separately. For
the ‘views about sperm banking’ items, a principal components
analysis failed to show a simple multifactorial structure due to
cross-loadings on several items. Therefore, all items were analysed
separately.
RESULTS
There were no differences between the two hospitals on any
measured demographic, medical or psychological variables, and
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therefore data were combined in subsequent analyses. Some men
completed the T1 questionnaire before banking (N¼ 16, 36.4%),
whereas the remainder banked sperm between 2 and 4 weeks
previously (N¼ 28, 63.6%). Comparisons were made between men
who completed questionnaires before banking and those who
completed them immediately after banking, but there were no
significant differences on any variables and therefore these groups
were also combined in subsequent analyses.
Of the 105 men identified as eligible to take part in the study, 91
(Sheffield¼ 68; Leeds¼ 23) returned questionnaires at T1
(response rate: 86.7%) and 78 men (85.7%: Sheffield¼ 58;
Leeds¼ 20) returned questionnaires at 1-year follow-up (T2). Of
the 13 men who did not return questionnaires at T2, 7 were lost to
follow-up or had relocated, 5 had died and 1 was in palliative care.
All further analyses were conducted for the men who returned
questionnaires at both time points (N¼ 78). Demographic
characteristics for the whole sample and for those who chose to
bank sperm (N¼ 44) and those who did not (N¼ 34) are shown in
Table 1 and medical information in Table 2.
All men remembered being told about the risks of infertility
from cancer treatment and that they could bank sperm before
treatment. Many (65.4%) reported receiving the information from
more than one source. At both time points, most men (T1¼ 71.8%;
T2¼ 69.2%) reported being told about the infertility risk by their
oncology consultant, and/or a nurse (T1¼ 55.1%; T2¼ 48.7%),
and/or by their General Practitioner (GP (T1¼ 52.6%;
T2¼ 51.3%). The same three sources were also most likely to
mention the possibility of sperm banking: oncology consultant
(T1¼ 71.8%; T2¼ 66.2%) and/or nurse (T1¼ 53.8%, T2¼ 50.6%)
and/or their GP (T1¼ 50%; T2¼ 42.9%). At T1, 57.7% of men
reported they had seen written information about sperm banking,
5.1% from multiple sources. In all, 40 men (51.3%) had seen a
brochure/booklet about sperm banking, 8 (10.3%) had checked
websites for information.
Demographic, medical and psychological variables predicting
the banking decision on diagnosis (T1). According to medical
records, 44 men (56.4%: Sheffield¼ 30; Leeds¼ 14) chose to bank
their sperm before commencing cancer treatment. In all, 16
(37.2%) banked one sample, 21 (48.8%) banked two and 7 (14%)
banked three samples. Younger men and those who did not already
have children were more likely to bank sperm (Table 1) but there
were no significant differences in terms of their relationship status,
age when they left full-time education, employment status, living
status or ethnicity. There were also no significant differences
between bankers and non-bankers in terms of medical variables
such as diagnosis (testicular vs other), treatment given, any
additional medical conditions or the time (weeks) between referral
to oncologist and beginning treatment (Table 2).
Variables that predicted the banking decision at T1 included a
greater desire for children in the future (OR¼ 8.19; 95% CI¼
3.53–19.01; Po0.001), reporting that the experience of cancer had
increased the wish to have children (OR¼ 2.64; 95% CI¼
1.15–6.09; Po0.001). They also were more likely to think they
would have more regrets at a later date if they did not bank
(OR¼ 3.51; 95% CI¼ 1.93–6.39; Po0.001). The item ‘knowing my
sperm is/was banked makes me feel more of a complete man’, did
not meet the assumption of linearity of the logit and was
dichotomised (agree/disagree) and entered as a categorical
predictor. Men who agreed with this statement were significantly
more likely to bank sperm (OR¼ 3.40; 95% CI¼ 1.09–0.59;
P¼ 0.035). At T1, those who banked sperm reported better
function, lower symptom and better total HRQoL scores than
those who did not bank sperm. Bankers were more likely to be
among the highest scoring 50% in total HRQoL (bankers 60.47%;
non-bankers 35.29%, P¼ 0.028); function (bankers 60.45%; non-
bankers 32.35%; P¼ 0.014) and the lowest scoring 50% on symptom
scores (bankers 34.88%; non-bankers 34.88%; P¼ 004). Illness
perceptions, satisfaction with information exchange or quality of
time were not associated with the decision to bank sperm.
Those variables above that significantly predicted banking in
univariate models were entered into a hierarchical logistic
regression model to identify those that uniquely contributed to
the decision to bank (Table 3). In the first step, age and whether
they already have children was entered, followed by total HRQoL
and in the final step the views about sperm banking and desire for
children items were entered. The full model was significant in
distinguishing between bankers and non-bankers, w2 (7)¼ 52.25,
Po0.001, with ‘desire for children in the future’ being the only
variable to distinguish between bankers and non-bankers.
Differences between bankers and non-bankers 1 year after
diagnosis (T2). At T2, both bankers and non-bankers were
confident that they had made the right decision about banking
sperm (4.59±0.69 and 4.20±1.29, respectively) and there was no
significant difference in their level of confidence
(t(32.02)¼  1.40; P¼ 0.170). Bankers felt it was more important
to know about changes in fertility (4.39±0.92) compared with
non-bankers (3.07±1.51) (t(43.72)¼  4.28, Po0.001) and
reported significantly greater confidence in fertility recovery
(3.45±0.90 vs 2.94þ 0.74, t(75)¼  2.68; P¼ 0.009). Men who
banked sperm agreed to a significantly greater extent with the
Table 1. Background information for total sample and for bankers and
non-bankers at Time 1
Total
(N¼78)
Banker
(N¼44)
Non-
banker
(N¼34)
Odds ratio
(95% CI)
Relationship status
Partner 53 (67.9%) 30 (68.2%) 23 (67.6%) 1.03 (0.39–2.67)
Other 25 (32.1%) 14 (31.8%) 11 (32.4%)
Age left full-time education
Under 18
years
48 (61.5%) 25 (56.8%) 23 (67.6%) 0.63 (0.25–1.60)
Over 18
years
30 (38.5%) 19 (43.2%) 11 (32.4%)
Employment status
Working 49 (62.8%) 29 (65.9%) 20 (58.8%) 1.35 (0.54–3.41)
Not working 29 (37.2%) 15 (34.1%) 14 (41.2%)
Living status
With partner 50 (64.1%) 27 (61.4%) 23 (67.6%) 0.76 (0.30–1.95)
Other 28 (35.9%) 17 (38.6%) 11 (32.4%)
Ethnic status
White 68 (87.2%) 37 (84.1%) 31 (91.2%) 0.51 (0.12–2.15)
Other 10 (12.8%) 7 (15.9%) 3 (8.8%)
Have children already
Yes 36 (46.2%) 13 (29.5%) 23 (67.6%) 4.99 (1.90–13.12)*
No 42 (53.8%) 31 (70.5%) 11 (32.4%)
Age at questionnaire (years)
Mean (s.d.) 33.00
(7.71)
29.49
(6.71)
37.55
(6.50)
0.26 (0.14–0.50)*
Abbreviations: CI¼ confidence interval; s.d.¼ standard deviation. *Significance level
Po0.001.
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statement ‘I like to know as much as possible about the effects of
treatment on my fertility’ (3.86±1.05 vs 3.06±1.17; t(75)¼
 3.17;P¼ 0.002) and disagreed with the statement ‘I don’t want
to know if my fertility has recovered or not’ (4.30±1.05 vs
2.97±1.21; t(75)¼  5.14; Po0.001).
At both time points, bankers scored significantly more positively
than non-bankers on function, symptom and total scores, and
there were significant improvements over time on all three
measures for the total sample. The absence of significant
bank time interactions indicated that both bankers and
non-bankers improved to comparable extents. Mean scores and
F-ratios are shown in Table 4.
Predictors of decision to bank in those unsure about whether or
not they want children in the future. In a subsample of men
(n¼ 36) who were unsure about whether they wanted children in
the future, 24 (66.7%) chose to bank sperm. Men who chose to
bank sperm were less likely to have children compared with non-
bankers (20.8 vs 83.3%; Po0.001). As shown in Table 5, they were
significantly younger, reported greater satisfaction with the
quality of time in appointments, less worry about children born
from banked sperm and about effects of cancer treatment on
children born after treatment than those who did not bank. Those
who chose to bank were significantly more sure about what to do,
were clearer about the decision that was best for them and
more strongly agreed with the statement ‘If I don’t bank now,
I think I will regret it later.’ At T2 there were no differences
between bankers and non-bankers in this subgroup, except
that bankers reported it was more important to know about
changes in their fertility than non-bankers (4.33±0.87 vs
2.70±1.34; t(32)¼  4.25; Po0.001).
DISCUSSION
Previous work has identified a number of variables associated with
men’s decisions about sperm banking on diagnosis. We sought to
extend these findings and consider the implications of these
decisions 1 year later. Our finding that just over half the
sample (56.4%) chose to bank their sperm before commencing
cancer treatment is higher than reported in previous
work (reviewed by Pacey and Eiser, 2011). Comparable figures
have ranged from as low as 2.9% in Taiwan (Chang et al, 2006) to
24% in the United Status (Schover et al, 2002; Girasole et al,
2007). The higher rate found in our study might be expected
given that at both recruitment sites, sperm banking is offered
free of charge in accordance with NICE guidelines
(National Collaborating Centre for Women’s and Children’s
Health, 2004). Staff were well informed about the rationale
for sperm banking and had relatively easy access to large well-
established sperm banks.
Our findings are consistent with much previous work describing
characteristics of why men bank sperm (Lass et al, 2001; Schover
et al, 2002; Saito et al, 2005; Girasole et al, 2007). Men who bank
sperm are more likely to be younger, less likely to have children
and especially more likely to want a child in the future. Despite
measuring a wider range of variables than previously reported, we
found that the only variable that predicted between bankers and
non-bankers on diagnosis was their desire for children.
Table 3. Hierarchical logistic regression to distinguish between bankers and non-bankers (Time 1)
Demographic þQuality of life
þViews about sperm
banking and desire for
children
OR (95% CI) Sig. OR (95% CI) Sig. OR (95% CI) Sig.
Age (at questionnaire) 0.25 (0.13–0.51) o0.001 0.21 (0.10–0.46) o0.001 0.46 (0.17–1.23) 0.124
Have children already (no) 2.78 (0.89–8.72) 0.079 2.27 (0.68–7.53) 0.180 1.92 (0.41–8.92) 0.405
Total HRQoL
(highest HRQoL)
3.39 (1.10–14.10) 0.036 0.62 (0.10–3.95) 0.615
Knowing my sperm is/was banked makes me feel
more of a complete man (agree)
0.88 (0.13–5.78) 0.890
If I don’t/didn’t bank now, I think I will regret it later 1.83 (0.75–4.44) 0.184
Effect of cancer on wish for children 1.80 (0.50–6.46) 0.366
Desire for children in the future 5.13 (1.72–15.23) 0.003
Abbreviations: CI¼ confidence interval; HRQoL¼health-related quality of life; s.d.¼ standard deviation; sig¼ significance. Demographic: Nagelkerke R2¼ 0.43. þQuality of life: Nagelkerke
R2¼ 0.48. þViews about sperm banking and desire for children: Nagelkerke R2¼ 0.69.
Table 2. Medical data for total sample and for bankers and non-bankers
at Time 1
Total
(N¼78)
Banker
(N¼44)
Non-
banker
(N¼34)
Odds ratio
(95% CI)
Diagnosis
Testicular 50 (64.1%) 29 (65.9%) 21 (61.8%) 1.20 (0.47–3.04)
Other 28 (35.9%) 15 (34.1%) 13 (38.2%)
Treatment
Chemotherapy 62 (81.6%) 33 (75.0%) 29 (90.6%) 1.14 (0.08–16.95)
Radiotherapy 5 (6.6%) 4 (15.9%) 1 (3.1%) 0.33 (0.06–1.69)
Combined 9 (11.8%) 7 (15.9%) 2 (6.2%)
Biopsy 21 (26.9%) 12 (27.3%) 9 (26.5%) 1.04 (0.38–2.86)
Additional
medical
condition
27 (34.6%) 14 (31.8%) 13 (38.2%) 0.75 (0.30–1.93)
Weeks from diagnosis to treatment
Mean (s.d.) 5.97 (7.48) 5.65 (4.54) 4.61 (2.80) 1.09 (0.94–1.26)
Abbreviations: CI¼ confidence interval; s.d¼ standard deviation.
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After 1 year, those who banked felt their fertility had
been less compromised and recognised the value of
knowing about changes in fertility, perhaps reflecting greater
awareness about the possibility of fertility recovery than non-
bankers.
It is easy to understand that the decision to bank is highly
motivated by a desire for children, so what is perhaps more
interesting is what men take into account when they are not certain
they want children in the future. Among a subsample unsure about
whether or not they wanted children in the future, those who
banked were more satisfied with quality of their clinic
appointments and had less concerns about the health of children
born after cancer treatment. They also reported that their decision
to bank was in part motivated to avoid regret in the future. Many
young men who are faced with the diagnosis of cancer may
have never thought about whether or not they want children in
the future. It is therefore especially important that clinicians take
time to discuss fertility options with these men and address specific
concerns, such as the health of future biological children.
Previous work also suggests the advice of the oncologist is
important in helping men decide whether to bank sperm (Yee et al,
2011). We previously found that men relied on oncologists to
arrange appointments at the sperm bank and that men were more
likely to bank where they held more positive views about the clinic
consultations before banking (Eiser et al, 2011), again suggesting
that medical staff play a critical role in facilitating decisions about
banking.
Although a number of studies have investigated HRQoL in men
following testicular cancer (Rossen et al, 2009), no past
work has specifically investigated how far HRQoL is affected by
sperm banking, either on diagnosis or in the longer term. On
diagnosis, we found that bankers reported better HRQoL
and fewer symptoms than non-bankers, perhaps suggesting that
those who agree to bank do so in part because they feel
strong enough to undertake the extra clinic appointments
necessary, or feel more optimistic about their survival and
therefore think it is more worthwhile. These differences
between bankers and non-bankers persisted 1 year later,
while, as might be expected, HRQoL improved for both groups
over this period. Thus, although the decision to bank sperm
was associated with better HRQoL, our findings do not support a
causal interpretation that subsequent HRQoL is enhanced by
deciding to bank.
Limitations. Our follow-up (1 year) was relatively short. At this
time, men may not be aware whether or not their fertility has
recovered. We recruited men with good prognoses and decisions
may be far more complex for those where the outcomes are less
clear. More extensive medical data (including staging) would be
valuable in future work. We used standardised questionnaires
where possible but given that there has been relatively little
previous work in the United Kingdom, we made changes to
previously reported scales to be culturally appropriate and
developed others. These varied in reliability and suggest that a
priority for future work is to develop standardised measures that
are sensitive to the issues relevant to men whose fertility is
potentially compromised because of cancer treatment. This work
was conducted in two centres in the United Kingdom, both of
which offered free banking and storage for men with cancer.
Previous work is not always clear about whether or not men have
to pay for long-term storage, and this may account for some
Table 4. Comparisons of quality of life between bankers and non-bankers at T1 and T2: means and F-ratios
Means and (s.d.) F(1,75) and P-values
Bankers (N¼43) Non-bankers (N¼34) Bank Time Bank time
HRQoL Time 1 Time 2 Time 1 Time 2
Function 82.67 (15.24) 89.65 (12.09) 74.49 (15.86) 84.05 (20.82) 4.82 (0.031) 18.67 (o0.001) 0.45 (0.503)
Symptoms 11.74 (11.71) 9.49 (11.36) 21.01 (16.63) 14.85 (20.23) 6.38 (0.014) 5.08 (0.027) 1.10 (0.299)
Total 85.43 (12.56) 89.58 (11.27) 76.59 (15.33) 84.20 (19.93) 5.99 (0.017) 11.17 (o0.001) 0.97 (0.328)
Abbreviations: HRQoL¼ health-related quality of life; s.d.¼ standard deviation; T1¼Time 1; T2¼Time 2. Higher scores on function and total scales represent higher HRQoL, but higher scores
on the symptom scale represent worse HRQoL.
Table 5. Summary of results predicting decisions to bank among those
unsure about their desire for children in the future
Banker
(N¼24)
Non-
banker
(N¼12)
Mean
(s.d.)
Mean
(s.d.)
OR (95% CI) Sig.
Age (years) 29.11 (7.59) 35.23 (7.20) 0.42 (0.19–0.95) 0.037
Satisfaction with
appointments
4.25 (0.46) 3.74 (0.59) 8.74 (1.34–56.97) 0.023
Satisfaction with
quality of time at
appointments
4.19 (0.53) 3.43 (0.90) 3.33 (1.32–8.42) 0.011
Worry that children
born from banked
sperm will have
health problems
2.29 (0.86) 3.25 (0.87) 0.25 (0.08–0.76) 0.015
Worry that my
cancer treatment
could cause health
problems for
children born
afterwards
2.46 (0.93) 3.42 (0.99) 0.30 (0.11–0.81) 0.018
I am/was unsure
what to do
3.21 (0.83) 2.50 (0.67) 0.38 (0.16–0.89) 0.025
It is/was clear what
choice is/was
best for me
3.38 (0.65) 2.75 (0.75) 2.71 (1.10–6.67) 0.031
If I don’t/didn’t
bank now, I think
I will regret it later
3.08 (0.78) 2.33 (0.78) 3.83 (1.23–11.90) 0.020
Abbreviations: CI¼ confidence interval; s.d.¼ standard deviation; sig¼ significance.
BRITISH JOURNAL OF CANCER Sperm banking and health-related quality of life
6 www.bjcancer.com |DOI:10.1038/bjc.2013.57
differences in findings associated with the policy of different
health-care systems.
Work of this kind is often criticised for poor response rates,
attributed to men’s general reluctance to take part in health-related
research (Kraemer, 2000). In fact, our initial response rate of
86.67% was relatively good and remained so at the 1-year follow-
up (85.7%), suggesting perhaps that fertility is a highly important
issue for these men.
CONCLUSION
Previous work suggesting that few men are willing to bank sperm
may in part be a consequence of methodological problems,
especially where no account is taken of whether or not men already
have children or wish to have a child in the future. We conclude
that the principal reason why men bank sperm on diagnosis is
whether or not they want to have children in the future. The
implications are that men may sacrifice their chance to have
children because they do not anticipate how they might feel about
this in the future. For those men who are uncertain about
future reproductive plans, decisions depend more on their HRQoL
on diagnosis and satisfaction with clinic care. Among this
group, those who did not bank were younger, less likely to have
had children, more concerned about the health of children
born after cancer and less certain about what they should
do. We conclude that these men deserve sensitive counselling
that promotes consideration of the future consequences of
compromised fertility.
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